{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:57:39Z","timestamp":1771462659481,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.reuma.2020.09.006","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T09:18:58Z","timestamp":1606468738000},"page":"105-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impacto econ\u00f3mico asociado a eventos obst\u00e9tricos en mujeres en edad f\u00e9rtil con artritis psori\u00e1sica, artritis reumatoide, espondiloartritis axial y psoriasis en Espa\u00f1a"],"prefix":"10.1016","volume":"18","author":[{"given":"Nuria","family":"Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Villar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onica","family":"Armijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Castellanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Marin Huarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Mareque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"Casado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Mart\u00ednez-Barrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2020.09.006_bib0185","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3899\/jrheum.091461","article-title":"Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities","volume":"85","author":"El-Gabalawy","year":"2010","journal-title":"J Rheumatol Suppl."},{"key":"10.1016\/j.reuma.2020.09.006_bib0190","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/pgmj.2006.052688","article-title":"Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution","volume":"83","author":"Kuek","year":"2007","journal-title":"Postgrad Med J."},{"key":"10.1016\/j.reuma.2020.09.006_bib0195","first-page":"e201903013","article-title":"La prevalencia de diez enfermedades inflamatorias inmunomediadas (IMID) en Espa\u00f1a","volume":"93","author":"Puig","year":"2019","journal-title":"Rev Esp Salud Publica."},{"key":"10.1016\/j.reuma.2020.09.006_bib0200","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/acr.22516","article-title":"Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases","volume":"67","author":"Kavanaugh","year":"2015","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.reuma.2020.09.006_bib0205","unstructured":"Instituto Nacional de Estad\u00edstica (INE). Nota de prensa: Cifras de poblaci\u00f3n a 1 de enero de 2019. Disponible en: https:\/\/www.ine.es\/prensa\/pad_2019_p.pdf"},{"key":"10.1016\/j.reuma.2020.09.006_bib0210","unstructured":"Sociedad Espa\u00f1ola de Reumatolog\u00eda (SER). Actualizaci\u00f3n de la Gu\u00eda de Pr\u00e1ctica Cl\u00ednica para el manejo de la artritis reumatoide en Espa\u00f1a; 2011. Disponible en: http:\/\/www.ser.es\/profesionales\/que-hacemos\/investigacion\/guias-de-practica-clinica\/"},{"key":"10.1016\/j.reuma.2020.09.006_bib0215","doi-asserted-by":"crossref","first-page":"e004081","DOI":"10.1136\/bmjopen-2013-004081","article-title":"Family planning and pregnancy issues for women with systemic inflammatory diseases: patient and physician perspectives","volume":"4","author":"Chakravarty","year":"2014","journal-title":"BMJ Open."},{"key":"10.1016\/j.reuma.2020.09.006_bib0220","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","article-title":"The epidemiology of psoriatic arthritis","volume":"41","author":"Ogdie","year":"2015","journal-title":"Rheum Dis Clin North Am."},{"key":"10.1016\/j.reuma.2020.09.006_bib0225","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.berh.2009.12.004","article-title":"Managing contraception and pregnancy in the rheumatologic diseases","volume":"24","author":"Clowse","year":"2010","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"10.1016\/j.reuma.2020.09.006_bib0230","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/BOR.0b013e328363ebf7","article-title":"Pathogenesis of pregnancy complications in systemic lupus erythematosus","volume":"25","author":"Ostensen","year":"2013","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.reuma.2020.09.006_bib0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/03009740903449313","article-title":"The management of rheumatic diseases in pregnancy","volume":"39","author":"Mitchell","year":"2010","journal-title":"Scand J Rheumatol."},{"key":"10.1016\/j.reuma.2020.09.006_bib0240","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/art.40821","article-title":"No association of discontinuing tumor necrosis factor inhibitors before gestational week twenty in well-controlled rheumatoid arthritis and juvenile idiopathic arthritis with a disease worsening in late pregnancy","volume":"71","author":"F\u00f6rger","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.reuma.2020.09.006_bib0245","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/BOR.0000000000000045","article-title":"Disease activity or remission of rheumatoid arthritis before, during and following pregnancy","volume":"26","author":"De Man","year":"2014","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.reuma.2020.09.006_bib0250","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1002\/art.24914","article-title":"Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study","volume":"60","author":"de Man","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reuma.2020.09.006_bib0255","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3899\/jrheum.140583","article-title":"Disease severity and pregnancy outcomes in women with rheumatoid arthritis: Results from the Organization of Teratology Information Specialists Autoimmune Diseases in Pregnancy Project","volume":"42","author":"Bharti","year":"2015","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reuma.2020.09.006_bib0260","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.reuma.2016.05.003","article-title":"Recomendaciones sobre actuaciones a seguir durante la edad f\u00e9rtil, el embarazo, posparto y lactancia en pacientes con enfermedades reum\u00e1ticas inflamatorias y autoinmunes","volume":"13","author":"Mart\u00ednez L\u00f3pez","year":"2017","journal-title":"Reumatol Clin."},{"key":"10.1016\/j.reuma.2020.09.006_bib0265","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1185\/030079906X104641","article-title":"Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001-2002","volume":"22","author":"Robinson","year":"2006","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.reuma.2020.09.006_bib0270","unstructured":"Grupo Espa\u00f1ol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU). Gu\u00eda pr\u00e1ctica para la implantaci\u00f3n de un modelo asistencial para la atenci\u00f3n integral de personas con enfermedades IMID; 2018. Disponible en: http:\/\/geteccu.org\/contenidos\/up\/2018\/10\/IMID-GUIA-DE-RECOMENDACIONES-02.pdf"},{"key":"10.1016\/j.reuma.2020.09.006_bib0275","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1590\/S1413-81232011000600016","article-title":"La sostenibilidad del Sistema Nacional de Salud en Espa\u00f1a","volume":"16","author":"Mart\u00edn Mart\u00edn","year":"2011","journal-title":"Cien Saude Colet."},{"key":"10.1016\/j.reuma.2020.09.006_bib0280","unstructured":"Coordinadora Nacional de Artritis y Confederaci\u00f3n de Asociaciones de enfermos de Crohn y Colitis Ulcerosa de Espa\u00f1a. Enfermedades inflamatorias inmunomediadas (IMID) e impacto laboral en Extremadura; 2017. Disponible en: http:\/\/www.conartritis.org\/wp-content\/uploads\/2017\/12\/Estudio_IMID.pdf"},{"key":"10.1016\/j.reuma.2020.09.006_bib0285","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ad.2016.09.004","article-title":"Serie de casos de pacientes psori\u00e1sicas expuestas a terapia biol\u00f3gica durante el embarazo Registro BIOBADADERM y revisi\u00f3n de la literatura","volume":"108","author":"Echeverr\u00eda-Garc\u00eda","year":"2017","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.reuma.2020.09.006_bib0290","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/bcp.12642","article-title":"Pregnancy outcome after TNF-\u03b1 inhibitor therapy during the first trimester: a prospective multicentre cohort study","volume":"80","author":"Weber-Schoendorfer","year":"2015","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.reuma.2020.09.006_bib0295","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/art.40508","article-title":"Pregnancy outcomes after exposure to certolizumab pegol: Updated results from a pharmacovigilance safety database","volume":"70","author":"Clowse","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.reuma.2020.09.006_bib0300","unstructured":"Consejo General de Colegios Oficiales de Farmac\u00e9uticos. Base de datos del Conocimiento Sanitario - Bot Plus 2.0 [Internet]. Madrid: Consejo General de Colegios Oficiales de Farmac\u00e9uticos; 2019. Disponible en: https:\/\/botplusweb.portalfarma.com\/"},{"key":"10.1016\/j.reuma.2020.09.006_bib0305","unstructured":"Ministerio de Sanidad, Servicios Sociales e Igualdad. Relaci\u00f3n informativa de medicamentos afectados por las deducciones establecidas en el Real Decreto Ley 8\/2010 de 20 de mayo por el que se adoptan medidas extraordinarias para la reducci\u00f3n del d\u00e9ficit p\u00fablico. [Internet]. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2010. Disponible en: https:\/\/www.mscbs.gob.es\/profesionales\/farmacia\/pdf\/DeduccionesMayo19.pdf"},{"key":"10.1016\/j.reuma.2020.09.006_bib0310","unstructured":"Sociedad Espa\u00f1ola de Neonatolog\u00eda. Nutrici\u00f3n enteral y parenteral de reci\u00e9n nacidos prematuros. Tablas Fenton sobre el crecimiento postnatal de reci\u00e9n nacidos prematuros; 2003. Disponible en: http:\/\/www.agapap.org\/druagapap\/system\/files\/VaronesCrecimientoFetalR.pdf"},{"key":"10.1016\/j.reuma.2020.09.006_bib0315","unstructured":"Oblikue Consulting. Base de datos de costes sanitarios eSalud [Internet]. Barcelona: Oblikue Consulting; 2019. Disponible en: http:\/\/www.oblikue.com\/bddcostes\/"},{"key":"10.1016\/j.reuma.2020.09.006_bib0320","unstructured":"Pearson Clinical & Talent Assesment. Bayley-III. Escalas Bayley de desarrollo infantil-III. Disponible en: https:\/\/www.pearsonclinical.es\/producto?producto=120&titulo=bayley-iii-escalas-bayley-de-desarrollo-infantil-iii"},{"key":"10.1016\/j.reuma.2020.09.006_bib0325","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1136\/annrheumdis-2015-207992","article-title":"Pregnancy outcomes in patients with ankylosing spondylitis: a nationwide register study","volume":"75","author":"Jakobsson","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2020.09.006_bib0330","doi-asserted-by":"crossref","first-page":"e0129567","DOI":"10.1371\/journal.pone.0129567","article-title":"Inflammatory bowel disease and risk of adverse pregnancy outcomes","volume":"10","author":"Boyd","year":"2015","journal-title":"PLoS One."},{"key":"10.1016\/j.reuma.2020.09.006_bib0335","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3899\/jrheum.160929","article-title":"Pregnancy outcomes in patients with psoriatic arthritis","volume":"44","author":"Mouyis","year":"2017","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reuma.2020.09.006_bib0340","first-page":"1091","article-title":"Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure","volume":"20","author":"Br\u00f6ms","year":"2014","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.reuma.2020.09.006_bib0345","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2796.2010.02239.x","article-title":"Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study","volume":"268","author":"N\u00f8rgaard","year":"2010","journal-title":"J Intern Med."},{"key":"10.1016\/j.reuma.2020.09.006_bib0350","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3899\/jrheum.110901","article-title":"Socioeconomic burden of immune-mediated inflammatory diseases--focusing on work productivity and disability","volume":"88","author":"Jacobs","year":"2011","journal-title":"J Rheumatol Suppl."},{"key":"10.1016\/j.reuma.2020.09.006_bib0355","first-page":"S664","article-title":"Immune-mediated inflammatory disorders (IMIDS): the economic and clinical costs","volume":"8","author":"Williams","year":"2002","journal-title":"Am J Manag Care."},{"key":"10.1016\/j.reuma.2020.09.006_bib0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/03946320140270S101","article-title":"The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases","volume":"27","author":"Blandizzi","year":"2014","journal-title":"Int J Immunopathol Pharmacol."}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X20302308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X20302308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:02:14Z","timestamp":1761663734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X20302308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1699258X20302308"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2020.09.006","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impacto econ\u00f3mico asociado a eventos obst\u00e9tricos en mujeres en edad f\u00e9rtil con artritis psori\u00e1sica, artritis reumatoide, espondiloartritis axial y psoriasis en Espa\u00f1a","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2020.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}